TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model

International Journal of Colorectal Disease

Volumn 21, Issue 2, 2006, Pages 143-154

  Cernaianu, Grigore ^a,b   Frank, Sibylle ^a   Erbstößer, Katrin ^a   Leonhardt, Sandy ^a   Cross, Michael ^b   McIvor, Zoe ^b   Scholz, Gabriele ^a   Dansranjavin, Temuujin ^a   Celik, Ilhan ^c   Tannapfel, Andrea ^a   Wittekind, Christian ^a   Troebs, Ralf Bodo ^a   Rothe, Karin ^a   Bennek, Joachim ^a   Hauss, Johann ^a   Witzigmann, Helmut ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angio genesis; Antiangiogenic therapy; Intravital microscopy; Minimal tumor disease; Tumor dormancy

Indexed keywords

CD34 ANTIGEN; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER DIAGNOSIS; CELL PROLIFERATION; CELL STRAIN; COLON CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; MALE; MICROSCOPY; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOHEXANES; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; SESQUITERPENES; TREATMENT FAILURE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 31544463513     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-005-0751-4     Document Type: Article

References (28)

1. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27-31
2. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557
3. Beecken WD, Fernandez A, Joussen AM, Achilles EG, Flynn E, Lo KM, Gillies SD, Javaherian K, Folkman J, Shing Y (2001) Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst 93:382-387
4. Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T (2002) Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Clin Cancer Res 8:2389-2398
5. Hotz HG, Reber HA, Hotz B, Sanghavi PC, Yu T, Foitzik T, Buhr HJ, Hines OJ (2001) Angiogenesis inhibitor tnp-470 reduces human pancreatic cancer growth. J Gastrointest Surg 5:131-138
6. Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A, Hawkins MJ (1999) A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer. Clin Cancer Res 5:1989-1995
7. Logothetis CJ, Wu KK, Finn LD, Daliani D, Figg W, Ghaddar H, Gutterman JU (2001) Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res 7:1198-1203
8. Stadler WM, Kuzel T, Shapiro C, Sosman J, Clark J, Vogelzang NJ (1999) Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma. J Clin Oncol 17:2541-2545
9. Drixler TA, Rinkes IH, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE (2000) Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60:1761-1765
10. Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP Jr, Schabel FM Jr (1984) Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res 44:717-726
11. Ogawa H, Sato Y, Kondo M, Takahashi N, Oshima T, Sasaki F, Une Y, Nishihira J, Todo S (2000) Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo. Oncol Rep 7:467-472
12. Asaishi K, Endrich B, Gotz A, Messmer K (1981) Quantitative analysis of microvascular structure and function in the amelanotic melanoma a-mel-3. Cancer Res 41:1898-1904
13. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
14. Guba M, Cernaianu G, Koehl G, Geissler EK, Jauch KW, Anthuber M, Falk W, Steinbauer M (2001) A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res 61:5575-5579
15. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie-Shepherd SR, Folkman J (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61:7669-7674
16. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8
17. Li CY, Shan S, Huang Q, Braun RD, Lanzen J, Hu K, Lin P, Dewhirst MW (2000) Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92:143-147
18. Watson JC, Sutanto-Ward E, Osaku M, Weinstein JK, Babb JS, Sigurdson ER (1999) Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/Trb colorectal hepatic metastases in bd-ix rats. Surgery 126:358-363
19. Bond SJ, Klein SA, Anderson GL, Wittliff JL (2000) Interaction of angiogenesis inhibitor TNP-470 with basic fibroblast growth factor receptors. J Surg Res 92:18-22
20. Holmgren L, O'Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153
21. Kato H, Ishikura H, Kawarada Y, Furuya M, Kondo S, Kato H, Yoshiki T (2001) Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: A study using TNP-470. Jpn J Cancer Res 92:67-73
22. Shishido T, Yasoshima T, Denno R, Mukaiya M, Sato N, Hirata K (1998) Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin. Jpn J Cancer Res 89:963-969
23. Benson AB III, Mulcahy MF (2002) Recent and ongoing clinical trials for treating colorectal cancer. Expert Opin Investig Drugs 11:871-880
24. Tebbutt NC, Cattell E, Midgley R, Cunningham D, Kerr D (2002) Systemic treatment of colorectal cancer. Eur J Cancer 38:1000-1015
25. Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D, Johnston P, Kerr D, Koehne CH, Labianca R, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ (2002) Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer 38:1429-1436
26. Deans GT, Parks TG, Rowlands BJ, Spence RA (1992) Prognostic factors in colorectal cancer. Br J Surg 79:608-613
27. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685-689
28. Sanchez-Cespedes M, Esteller M, Hibi K, Cope FO, Westra WH, Piantadosi S, Herman JG, Jen J, Sidransky D (1999) Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res 5:2450-2454